- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
-
Kim HD, Kim BJ, Kim HS, Kim JH
- KMID: 2448353
- Korean J Intern Med.
- 2019 May;34(3):608-617.
- doi: 10.3904/kjim.2017.063
BACKGROUND/AIMS: The Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST) or European Organization for Research and Treatment of Cancer (EORTC) criteria are used to assess metabolic tumor responses. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Response Evaluation after Treatment and Post-treatment Surveillance of Hepatocellular Carcinoma
-
Yoon JS, Park SY
- KMID: 2409643
- J Liver Cancer.
- 2018 Mar;18(1):9-16.
- doi: 10.17998/jlc.18.1.9
Hepatocellular carcinoma is one of the most prevalent malignancies and frequent causes of death worldwide. Treatment options of hepatocellular carcinoma consist of locoregional therapy, surgical resection, liver transplantation, and systemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Response Evaluation of Chemotherapy for Lung Cancer
-
Hwang KE, Kim HR
- KMID: 2375982
- Tuberc Respir Dis.
- 2017 Apr;80(2):136-142.
- doi: 10.4046/trd.2017.80.2.136
Assessing response to therapy allows for prospective end point evaluation in clinical trials and serves as a guide to clinicians for making decisions. Recent prospective and randomized trials suggest the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Response Evaluation Criteria in Solid Tumors with Volumetric Measurement for Evaluation of Response and Overall Survival with Liver Metastases from Colorectal Cancer
-
Lee IS, Choi SJ, Seo CR, Kim JS
- KMID: 2459016
- J Korean Soc Radiol.
- 2019 Sep;80(5):906-918.
- doi: 10.3348/jksr.2019.80.5.906
PURPOSE: The aim of this study was to compare the measurements of diameter and volume of hepatic metastases from CT images with the overall survival and tumor response, in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
-
Han KS, Sohn DK, Kim DY, Kim BC, Hong CW, Chang HJ, Kim SY, Baek JY, Park SC, Kim MJ, Oh JH
- KMID: 2454334
- Cancer Res Treat.
- 2016 Apr;48(2):567-573.
- doi: 10.4143/crt.2015.195
PURPOSE: Local excision may be an another option for selected patients with markedly down-staged rectal cancer after preoperative chemoradiation therapy (CRT), and proper evaluation of post-CRT tumor stage (ypT) is... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Nonsteroidal Anti-inflammatory Drug in Treatment of Extra-abdominal Desmoid Tumors
-
Cho JY, Gupta S, Cho HS, Park MS, Mok SJ, Han I, Kim HS
- KMID: 2411749
- Clin Orthop Surg.
- 2018 Jun;10(2):225-233.
- doi: 10.4055/cios.2018.10.2.225
BACKGROUND: We retrospectively reviewed the outcomes of patients who had been treated with meloxicam for the extra-abdominal desmoid tumors and evaluated the correlation between clinical outcome and clinic pathological variables. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy
-
Choi Y, Kim S, Kwak DW, Lee HS, Kang MK, Lee DK, Hur WJ
- KMID: 2418871
- Radiat Oncol J.
- 2018 Jun;36(2):114-121.
- doi: 10.3857/roj.2018.00031
PURPOSE: To explore the feasibility of maximum diameter as a response assessment method for vestibular schwannomas (VS) after stereotactic radiosurgery or fractionated stereotactic radiotherapy (RT), we analyzed the concordance of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Invasion that Showed Favorable Prognosis after Combined External Radiation Therapy and Sorafenib Therapy
-
Paik N, Sinn DH, Park HC, Jeong WK, Kim MS, Kim JH, Yang B
- KMID: 2357344
- J Liver Cancer.
- 2016 Sep;16(2):134-138.
- doi: 10.17998/jlc.2016.16.2.134
A prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is dismal that the median survival is 2 to 4 months without treatment. Sorafenib, the standard regimen of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study
-
Gupta M, Choudhury , Rawal S, Goel HC, Rao SA
- KMID: 2431979
- Nucl Med Mol Imaging.
- 2018 Dec;52(6):420-429.
- doi: 10.1007/s13139-018-0548-3
PURPOSE: The aim of the study was to compare response evaluation criteria in solid tumours 1.1 (RECIST 1.1), positron emission tomography response criteria in solid tumours (PERCIST), European organisation for... -
- CITED
-
- Close
- SHARE
-
- Close
- Expanding Indications of Endoscopic Submucosal Dissection for Early Gastric Cancer: Hope or Hype?
-
Lee H, Lee JH
- KMID: 2380753
- Gut Liver.
- 2015 Mar;9(2):135-136.
- doi: 10.5009/gnl15008
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
-
Sayan M, Zoto Mustafayev T, Sahin B, Kefelioglu ESS, Wang SJ, Kurup V, Balmuk A, Gungor G, Ohri N, Weiner J, Ozyar E, Atalar B
- KMID: 2468735
- Radiat Oncol J.
- 2019 Dec;37(4):265-270.
- doi: 10.3857/roj.2019.00409
PURPOSE: Renal cell carcinoma (RCC) and melanoma have been considered ‘radioresistant’ due to the fact that they do not respond to conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
-
Yu JI, Yoo GS, Cho S, Jung SH, Han Y, Park S, Lee B, Kang W, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC
- KMID: 2418882
- Radiat Oncol J.
- 2018 Mar;36(1):25-34.
- doi: 10.3857/roj.2017.00409
PURPOSE: This study aimed to evaluate the initial outcomes of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) in terms of tumor response and safety. MATERIALS AND METHODS: HCC patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer
-
Lee DH, Kim SH, Lee SM, Han JK
- KMID: 2440482
- Korean J Radiol.
- 2019 Apr;20(4):589-598.
- doi: 10.3348/kjr.2018.0306
OBJECTIVE: To evaluate whether data acquired from perfusion computed tomography (PCT) parameters can aid in the prediction of treatment outcome after palliative chemotherapy in patients with unresectable advanced gastric cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Quantitative Methods on FDG PET/CT for Treatment Response Evaluation of Metastatic Colorectal Cancer
-
Bang JI, Lim Y, Paeng JC, Han SW, Park S, Lee JM, Kim HJ, Cheon GJ, Lee DS, Chung JK, Kim TY, Kang KW
- KMID: 2446895
- Nucl Med Mol Imaging.
- 2017 Jun;51(2):147-153.
- doi: 10.1007/s13139-016-0449-2
PURPOSE: FDG PET is effective in treatment response evaluation of cancer. However, there is no standard method for quantitative evaluation of FDG PET, particularly regarding cytostatic drugs. We compared various... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer
-
Kim IH, Lee JE, Yang JH, Jeong JW, Ro S, Oh ST, Kim JG, Choi MH, Lee MA
- KMID: 2403497
- Cancer Res Treat.
- 2018 Jan;50(1):283-292.
- doi: 10.4143/crt.2016.537
PURPOSE: The purpose of this study was to investigate the prognostic implications of carcinoembryonic antigen (CEA) levels that are inconsistent with Response Evaluation Criteria in Solid Tumor (RECIST) responses in... -
- CITED
-
- Close
- SHARE
-
- Close
- Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review
-
Kim TS, Kim JH, Kim BH, Lee YS, Yoo YJ, Kang SH, Suh SJ, Jung YK, Seo YS, Yim HJ, Yeon JE, Byun KS
- KMID: 2406043
- Clin Mol Hepatol.
- 2017 Dec;23(4):340-346.
- doi: 10.3350/cmh.2016.0070
Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer
-
Heo YJ, Kang SY, Kim ST, Kang WK, Lee J, Kim KM
- KMID: 2470437
- Precis Future Med.
- 2019 Dec;3(4):165-175.
- doi: 10.23838/pfm.2019.00079
PURPOSE: Immune checkpoint blockades (ICB) have been successful in gastric cancer (GC). However, the majority of unselected patients with GC fail to respond to ICB. It is crucial to identify... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
-
Stintzing , von Einem , Fueweger C, Haidenberger A, Fedorov M, Muavcevic
- KMID: 2437612
- Cancer Res Treat.
- 2019 Jan;51(1):187-193.
- doi: 10.4143/crt.2017.594
PURPOSE: The treatment of liver metastases with local procedures is a fast progressing field. For the most, long-term survival data is missing raising questions with regard to the efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases
-
Huh J, Park J, Kim KW, Kim HJ, Lee JS, Lee JH, Jeong YK, Shinagare , Ramaiya NH
- KMID: 2424846
- Korean J Radiol.
- 2018 Dec;19(6):1066-1076.
- doi: 10.3348/kjr.2018.19.6.1066
OBJECTIVE: The reliability of size measurements of liver metastases from neuroendocrine tumors (NETs) on contrast-enhanced computed tomography (CT) phases made by different readers may be hampered due to transient, variable... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis
-
Hong SH, Kim YS, Lee JE, Kim IH, Kim SJ, Han D, Yoo IR, Chung YG, Kim YH, Lee KY, Kang JH
- KMID: 2344085
- Cancer Res Treat.
- 2016 Jul;48(3):1110-1119.
- doi: 10.4143/crt.2015.289
PURPOSE: The aim of this study was to analyze clinical characteristics of skeletal metastasis in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) and treatment outcomes of... -
- CITED
-
- Close
- SHARE
-
- Close
